EKF Diagnostics Holdings Plc (EKF) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.068x

Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has a cash flow conversion efficiency ratio of 0.068x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.79 Million ≈ $582.44 USD) by net assets (GBX70.28 Million ≈ $8.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EKF Diagnostics Holdings Plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

EKF Diagnostics Holdings Plc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how EKF Diagnostics Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EKF Diagnostics Holdings Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Niraj Ispat Industries Limited
NSE:NIRAJISPAT
0.006x
Fuse Cobalt Inc
V:FUSE
-0.057x
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
0.106x
Smartfren Telecom Tbk
JK:FREN
-0.016x
GCP Asset Backed Income Fund Limited
LSE:GABI
0.107x
Aptitude Software Group PLC
LSE:APTD
-0.016x
GlucoTrack Inc
NASDAQ:GCTK
-1.392x
Polledo S.A.
BA:POLL
0.130x

Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings Plc (2001–2025)

The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see EKF stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX70.28 Million
≈ $8.55K
GBX9.71 Million
≈ $1.18K
0.138x -25.95%
2024-12-31 GBX73.21 Million
≈ $8.91K
GBX13.66 Million
≈ $1.66K
0.187x +101.62%
2023-12-31 GBX68.22 Million
≈ $8.30K
GBX6.31 Million
≈ $767.87
0.093x -28.84%
2022-12-31 GBX74.52 Million
≈ $9.07K
GBX9.69 Million
≈ $1.18K
0.130x +20.30%
2021-12-31 GBX94.74 Million
≈ $11.53K
GBX10.24 Million
≈ $1.25K
0.108x -38.80%
2020-12-31 GBX78.20 Million
≈ $9.51K
GBX13.81 Million
≈ $1.68K
0.177x +146.43%
2019-12-31 GBX71.17 Million
≈ $8.66K
GBX5.10 Million
≈ $620.52
0.072x -44.98%
2018-12-31 GBX63.90 Million
≈ $7.78K
GBX8.32 Million
≈ $1.01K
0.130x -12.96%
2017-12-31 GBX60.50 Million
≈ $7.36K
GBX9.05 Million
≈ $1.10K
0.150x +2.02%
2016-12-31 GBX60.97 Million
≈ $7.42K
GBX8.94 Million
≈ $1.09K
0.147x +260.04%
2015-12-31 GBX46.75 Million
≈ $5.69K
GBX-4.29 Million
≈ $-521.36
-0.092x -68.80%
2014-12-31 GBX87.38 Million
≈ $10.63K
GBX-4.74 Million
≈ $-577.21
-0.054x -210.70%
2013-12-31 GBX40.92 Million
≈ $4.98K
GBX2.01 Million
≈ $244.19
0.049x +20.93%
2012-12-31 GBX39.43 Million
≈ $4.80K
GBX1.60 Million
≈ $194.55
0.041x +288.32%
2011-12-31 GBX37.43 Million
≈ $4.55K
GBX-806.00K
≈ $-98.07
-0.022x +64.04%
2010-12-31 GBX23.53 Million
≈ $2.86K
GBX-1.41 Million
≈ $-171.43
-0.060x +50.22%
2009-12-31 GBX5.62 Million
≈ $683.79
GBX-676.00K
≈ $-82.25
-0.120x +5.74%
2008-12-31 GBX5.07 Million
≈ $616.87
GBX-647.00K
≈ $-78.72
-0.128x -210.05%
2007-12-31 GBX4.98 Million
≈ $605.44
GBX577.00K
≈ $70.20
0.116x +160.35%
2006-12-31 GBX4.30 Million
≈ $523.06
GBX-826.00K
≈ $-100.50
-0.192x -3668.00%
2005-12-31 GBX3.71 Million
≈ $451.89
GBX20.00K
≈ $2.43
0.005x +101.97%
2004-12-31 GBX3.12 Million
≈ $379.01
GBX-852.00K
≈ $-103.66
-0.274x -2390.00%
2003-12-31 GBX2.46 Million
≈ $299.07
GBX-27.00K
≈ $-3.29
-0.011x -498.46%
2002-12-31 GBX2.90 Million
≈ $353.09
GBX8.00K
≈ $0.97
0.003x -99.58%
2001-12-31 GBX214.00K
≈ $26.04
GBX142.00K
≈ $17.28
0.664x --

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.36 Million
GBX11.15 Billion GBX
Market Cap Rank
#30299 Global
#754 in UK
Share Price
GBX25.90
Change (1 day)
-3.36%
52-Week Range
GBX21.80 - GBX31.90
All Time High
GBX78.21
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more